Richter Gedeon Vegyeszeti Gyar Nyrt
F:RIG2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Richter Gedeon Vegyeszeti Gyar Nyrt (RIG2) under the Base Case is 36.11 EUR per share. Compared with the current market price of 36.04 EUR, the stock appears Fairly Valued .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Richter Gedeon Vegyeszeti Gyar Nyrt Does
Richter Gedeon is a pharmaceutical company that develops, manufactures, and sells prescription medicines, with a strong focus on treatments for women’s health, central nervous system disorders, and some generic drugs. It also makes active pharmaceutical ingredients and drug products that are used in its own medicines and sold to other drugmakers. Its main customers are hospitals, doctors, pharmacies, health systems, and partner pharma companies in many countries.
- Headquarters
- Hungary HU
- Employees
- 11 955
- IPO date
- Nov 9, 1994
Richter Gedeon Vegyeszeti Gyar Nyrt has no economic moat
Richter Gedeon Vegyeszeti Gyar Nyrt lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysisBalance Sheet
Continue RIG2 Research
Decided on Richter Gedeon Vegyeszeti Gyar Nyrt? Get an email when RIG2 reaches the price you’d buy at. Free with an account.
Other Richter Gedeon Vegyeszeti Gyar Nyrt listings
What is the Intrinsic Value of one RIG2 stock?
The intrinsic value for Richter Gedeon Vegyeszeti Gyar Nyrt (RIG2) under the Base Case is 36.11 EUR.
Is RIG2 stock undervalued or overvalued?
Compared with the current market price of 36.04 EUR, the stock appears Fairly Valued .